NEUVOGEN is an immunoncology company applying a systems approach to develop therapeutic whole cell cancer vaccines to transform how cancer is treated.
Our mission is to serve patients with cancer by developing transformative therapies to meaningfully extend their lives.
NEUVOGEN’s vision is to revolutionize cancer treatment by harnessing the full power of a patient’s immune system to eliminate cancer from their body. We have taken a fundamentally different approach to solving cancer. Unlike other early-stage immunoncology companies, we try to solve for multiple issues arising from the complexity of cancer biology. Our approach to solving cancer is based on the concept that in order to fully address the complexity of solid tumor cancer biology, many targets and multiple biologic pathways need to be addressed simultaneously.
NEUVOGEN is advancing a broad pipeline of therapeutic whole cell cancer vaccine candidates designed to activate the patient’s immune system to target and eliminate existing tumors and prevent future metastases. Our research programs focus on therapeutic cancer vaccines to treat a wide range of tumor types across numerous solid tumor indications.
Company Details
- Employees
- 17
- Address
- 11095 Flintkote Avenue,
- in****@****gen.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- neuvogen.com
- Keywords
- Immunoncology, whole cell cancer vaccines, innovation, research, systems approach, transformative therapies, cancer, biotechnology, solid tumor.
- HQ
- San Diego, CA
Neuvogen, Inc. Questions
Neuvogen, Inc.'s website is neuvogen.com
Neuvogen, Inc.'s LinkedIn profile is https://www.linkedin.com/company/neuvogen
Neuvogen, Inc. has
17 employees.
View email and phone details for 17
employees at Neuvogen, Inc..
Neuvogen, Inc.'s industry is
Biotechnology Research
Neuvogen, Inc.'s top competitors are
Cargo Therapeutics,
Vertex Pharmaceuticals,
Lockton,
Capstan Therapeutics,
Fate Therapeutics Inc.,
Astrazeneca,
Nimble Therapeutics,
Gilead Sciences,
Nitto Biopharma,
Kyverna Therapeutics.
Neuvogen, Inc.'s support email address is info@neuvogen.com
Neuvogen, Inc.'s categories are Biotechnology Research
